iShares U.S. Pharmaceuticals ETF (IHE) |
| 90.98 0.25 (0.28%) 02-27 11:03 |
| Open: | 90.29 |
| High: | 91.03 |
| Low: | 90.29 |
| Volume: | 12,423 |
| Market Cap: | 705(M) |
| PE Ratio: | 24.74 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 107.72 |
| Resistance 1: | 92.23 |
| Pivot price: | 90.34 |
| Support 1: | 88.14 |
| Support 2: | 85.61 |
| 52w High: | 92.3 |
| 52w Low: | 58.97 |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 20 Jan 2026
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Wed, 07 Jan 2026
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - Yahoo Finance
Fri, 19 Dec 2025
Pharma's $370B Bet on America: The ETF Plays for 2026 - The Globe and Mail
Thu, 11 Dec 2025
3 Dividend ETFs to Buy and Hold for Life if the Market Crashes - 24/7 Wall St.
Tue, 09 Dec 2025
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal - Nasdaq
Thu, 27 Nov 2025
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
